批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/03/04 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:OSELTAMIVIR PHOSPHATE 剂型/给药途径:CAPSULE;ORAL 规格:EQ 30MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021087 |
003 |
NDA |
TAMIFLU |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
Yes |
No |
AB |
2007/07/02
|
ROCHE |
202595 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2016/08/03
|
NATCO |
208578 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2017/02/24
|
ZYDUS PHARMS |
209093 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2017/05/17
|
AMNEAL PHARMS |
207211 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2017/09/14
|
MACLEODS PHARMS LTD |
208348 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2018/01/09
|
LUPIN |
209438 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2018/02/23
|
HETERO LABS LTD III |
209421 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2018/06/08
|
STRIDES PHARMA |
211823 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2019/06/24
|
ALEMBIC |
212739 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2020/03/04
|
SUNSHINE |
212544 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2020/05/20
|
MSN |
215208 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2021/10/01
|
EPIC PHARMA LLC |
214726 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Discontinued |
No |
No |
AB |
2022/07/25
|
ACCORD HLTHCARE |
217467 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2023/10/03
|
INVAGEN PHARMS |
218565 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2024/05/01
|
LAURUS |
217133 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 30MG BASE |
Prescription |
No |
No |
AB |
2024/10/30
|
NANJING DAOQUN |
活性成分:OSELTAMIVIR PHOSPHATE 剂型/给药途径:CAPSULE;ORAL 规格:EQ 45MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021087 |
002 |
NDA |
TAMIFLU |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
Yes |
No |
AB |
2007/07/02
|
ROCHE |
202595 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2016/08/03
|
NATCO |
208578 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2017/02/24
|
ZYDUS PHARMS |
209093 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2017/05/17
|
AMNEAL PHARMS |
207211 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2017/09/14
|
MACLEODS PHARMS LTD |
208348 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2018/01/09
|
LUPIN |
209438 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2018/02/23
|
HETERO LABS LTD III |
209421 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2018/06/08
|
STRIDES PHARMA |
211823 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2019/06/24
|
ALEMBIC |
212739 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2020/03/04
|
SUNSHINE |
212544 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2020/05/20
|
MSN |
215208 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2021/10/01
|
EPIC PHARMA LLC |
214726 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Discontinued |
No |
No |
AB |
2022/07/25
|
ACCORD HLTHCARE |
217467 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2023/10/03
|
INVAGEN PHARMS |
218565 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 45MG BASE |
Prescription |
No |
No |
AB |
2024/05/01
|
LAURUS |
活性成分:OSELTAMIVIR PHOSPHATE 剂型/给药途径:CAPSULE;ORAL 规格:EQ 75MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021087 |
001 |
NDA |
TAMIFLU |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
Yes |
Yes |
AB |
1999/10/27
|
ROCHE |
202595 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2016/08/03
|
NATCO |
208578 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2017/02/24
|
ZYDUS PHARMS |
209093 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2017/05/17
|
AMNEAL PHARMS |
207211 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2017/09/14
|
MACLEODS PHARMS LTD |
208348 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2018/01/09
|
LUPIN |
209438 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2018/02/23
|
HETERO LABS LTD III |
209421 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2018/06/08
|
STRIDES PHARMA |
211823 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2019/06/24
|
ALEMBIC |
212739 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2020/03/04
|
SUNSHINE |
212544 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2020/05/20
|
MSN |
215208 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2021/10/01
|
EPIC PHARMA LLC |
214726 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Discontinued |
No |
No |
AB |
2022/07/25
|
ACCORD HLTHCARE |
217467 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2023/10/03
|
INVAGEN PHARMS |
218009 |
001 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2023/11/24
|
HAINAN POLY |
218565 |
003 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2024/05/01
|
LAURUS |
217133 |
002 |
ANDA |
OSELTAMIVIR PHOSPHATE |
OSELTAMIVIR PHOSPHATE |
CAPSULE;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2024/10/30
|
NANJING DAOQUN |